Cisplatin 50mg
| Product Overview |
| Generic Name | Cisplatin 50mg |
| Brand Name(s) | Platinol-AQ, Platinol, Cytoplatin, Ciszest, Celplat‑50 |
| Form | Intravenous injection (sterile aqueous solution, multi-dose vial) |
| Strength | 50 mg/50 mL |
| Therapeutic Class | Platinum-based alkylating antineoplastic agent |
| ATC Code | L01XA01 |
| Manufacturing & Regulatory |
| Manufacturer | Bristol-Myers Squibb, Accord Healthcare, Intas Pharma, Celon Labs, Ocean Pharma |
| Country | India/USA/EU |
| GMP Compliance | GMP-compliant (WHO/US FDA/Indian CDSCO approved) |
| DMF/CEP | #75-036 |
| COFEPRIS | 010.000.6291.00 |
| Free Sale Certificate | Yes |
| Logistics & Export |
| MOQ | 100 units |
| Shelf Life | 24 months |
| Storage | 2–8 °C |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 to 10 Days |
| Documentation |
| Certificate of Analysis (COA) | Yes |
| SDS | Upon Request |
| CTD Summary | CTD from originator; generic use abbreviated formats |
Description
Indications & Usage: Cogent anticancer agent used primarily in testicular, ovarian, bladder, cervical, head/neck, lung, esophageal malignancies; mechanism: DNA crosslinking by platinum moiety
Request for Quote
